Skip to main content
Erschienen in: Clinical Rheumatology 5/2018

31.01.2018 | Original Article

Unexplained cough: it is time to rule out Sjogren’s syndrome

verfasst von: Matthew Koslow, Shaye Kivity, Vicktoria Vishnevskia-Dai, Issahar Ben-Dov

Erschienen in: Clinical Rheumatology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Sjogren’s syndrome is associated with chronic cough, but sicca symptoms are missing from cough evaluation guidelines. We evaluated patients with unexplained cough for undiagnosed Sjogren’s syndrome. Patients referred to our pulmonary clinic (Sheba Medical Center, 2009 to 2012) with unexplained cough and concomitant dry eyes were selected for evaluation. Unexplained cough was defined as chronic cough of unknown etiology despite algorithm-based evaluation and treatment. Patients were evaluated in a dedicated clinic by a pulmonologist, rheumatologist, and ophthalmologist specializing in autoimmune disease. Patients completed the Leicester Cough Questionnaire, spirometry, antibody testing for anti Ro/La, ophthalmologic examination with visual acuity, eyelid, ocular surface fluorescein staining, tear break-up time and Schirmer’s test, full slit lamp, and fundus examinations. Four-year follow-up was conducted by telephone questionnaire. We identified 24 patients among which 22 (21 females) agreed for evaluation. Eight patients (36%), seven initially, and one during follow-up were diagnosed with Sjogren’s syndrome (SS) (six secondary and two primary SS). At 4-year follow-up, cough tended to persist and improve in only 37% with SS. These include 2 (Scl and RA) who received rituximab and 1 (stage 1 sarcoidosis) with spontaneous improvement. In contrast, cough improved in most (64%) patients without SS; the majority (eight/nine) report intensified disease-specific treatment (five allergic and three GERD). We describe patients in whom unexplained chronic cough was associated with dry eyes. Focused workup revealed undiagnosed Sjogren’s syndrome in 36%. Dry eyes, with or without SS, is under-recognized and should be added to diagnostic algorithms for unexplained cough.
Literatur
1.
Zurück zum Zitat Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58(4):339–343CrossRefPubMedPubMedCentral Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58(4):339–343CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM, American College of Chest P (2006) Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):1S–23S. https://doi.org/10.1378/chest.129.1_suppl.1S CrossRefPubMedPubMedCentral Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM, American College of Chest P (2006) Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):1S–23S. https://​doi.​org/​10.​1378/​chest.​129.​1_​suppl.​1S CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Poe RH, Kallay MC (2003) Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 123(3):679–684CrossRefPubMed Poe RH, Kallay MC (2003) Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 123(3):679–684CrossRefPubMed
7.
Zurück zum Zitat Smyrnios NA, Irwin RS, Curley FJ (1995) Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest 108(4):991–997CrossRefPubMed Smyrnios NA, Irwin RS, Curley FJ (1995) Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest 108(4):991–997CrossRefPubMed
10.
Zurück zum Zitat Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM (1993) Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 104(5):1511–1517CrossRefPubMed Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM (1993) Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 104(5):1511–1517CrossRefPubMed
13.
Zurück zum Zitat Constantopoulos SH, Drosos AA, Maddison PJ, Moutsopoulos HM (1984) Xerotrachea and interstitial lung disease in primary Sjogren’s syndrome. Respiration 46(3):310–314CrossRefPubMed Constantopoulos SH, Drosos AA, Maddison PJ, Moutsopoulos HM (1984) Xerotrachea and interstitial lung disease in primary Sjogren’s syndrome. Respiration 46(3):310–314CrossRefPubMed
14.
Zurück zum Zitat Strimlan CV, Rosenow EC 3rd, Divertie MB, Harrison EG Jr (1976) Pulmonary manifestations of Sjogren’s syndrome. Chest 70(03):354–361CrossRefPubMed Strimlan CV, Rosenow EC 3rd, Divertie MB, Harrison EG Jr (1976) Pulmonary manifestations of Sjogren’s syndrome. Chest 70(03):354–361CrossRefPubMed
17.
Zurück zum Zitat Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, NR MI, RT MK, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ (2000) Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161(1):309–329. https://doi.org/10.1164/ajrccm.161.1.ats11-99 CrossRefPubMed Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, NR MI, RT MK, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ (2000) Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161(1):309–329. https://​doi.​org/​10.​1164/​ajrccm.​161.​1.​ats11-99 CrossRefPubMed
18.
Zurück zum Zitat Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26(4):720–735. https://doi.org/10.1183/09031936.05.00034905 CrossRefPubMed Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26(4):720–735. https://​doi.​org/​10.​1183/​09031936.​05.​00034905 CrossRefPubMed
19.
Zurück zum Zitat Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Force AET (2005) General considerations for lung function testing. Eur Respir J 26(1):153–161. https://doi.org/10.1183/09031936.05.00034505 CrossRefPubMed Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Force AET (2005) General considerations for lung function testing. Eur Respir J 26(1):153–161. https://​doi.​org/​10.​1183/​09031936.​05.​00034505 CrossRefPubMed
20.
21.
Zurück zum Zitat Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26(3):511–522. https://doi.org/10.1183/09031936.05.00035005 CrossRefPubMed Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26(3):511–522. https://​doi.​org/​10.​1183/​09031936.​05.​00035005 CrossRefPubMed
27.
Zurück zum Zitat Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK (1978) Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 86(5):648–655CrossRefPubMed Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK (1978) Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 86(5):648–655CrossRefPubMed
28.
Zurück zum Zitat Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, De Palo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, Case Control Etiologic Study of Sarcoidosis research g (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164(10 Pt 1):1885–1889. https://doi.org/10.1164/ajrccm.164.10.2104046 CrossRefPubMed Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, De Palo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, Case Control Etiologic Study of Sarcoidosis research g (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164(10 Pt 1):1885–1889. https://​doi.​org/​10.​1164/​ajrccm.​164.​10.​2104046 CrossRefPubMed
29.
Zurück zum Zitat Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, Kitaichi M (2005) Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127(6):2019–2027CrossRefPubMed Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, Kitaichi M (2005) Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127(6):2019–2027CrossRefPubMed
31.
Zurück zum Zitat La Corte R, Bajocchi G, Potena A, Govoni M, Trotta F (1995) Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjogren’s syndrome. Ann Rheum Dis 54(8):636–639CrossRefPubMedPubMedCentral La Corte R, Bajocchi G, Potena A, Govoni M, Trotta F (1995) Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjogren’s syndrome. Ann Rheum Dis 54(8):636–639CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Gudbjornsson B, Hedenstrom H, Stalenheim G, Hallgren R (1991) Bronchial hyperresponsiveness to methacholine in patients with primary Sjogren’s syndrome. Ann Rheum Dis 50(1):36–40CrossRefPubMedPubMedCentral Gudbjornsson B, Hedenstrom H, Stalenheim G, Hallgren R (1991) Bronchial hyperresponsiveness to methacholine in patients with primary Sjogren’s syndrome. Ann Rheum Dis 50(1):36–40CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM (1991) Alveolitis correlates with clinical pulmonary involvement in primary Sjogren’s syndrome. Chest 99(6):1394–1397CrossRefPubMed Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM (1991) Alveolitis correlates with clinical pulmonary involvement in primary Sjogren’s syndrome. Chest 99(6):1394–1397CrossRefPubMed
35.
Zurück zum Zitat Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, Tuvim MJ, Adachi R, Romo I, Bordt AS, Bowden MG, Sisson JH, Woodruff PG, Thornton DJ, Rousseau K, De la Garza MM, Moghaddam SJ, Karmouty-Quintana H, Blackburn MR, Drouin SM, Davis CW, Terrell KA, Grubb BR, O’Neal WK, Flores SC, Cota-Gomez A, Lozupone CA, Donnelly JM, Watson AM, Hennessy CE, Keith RC, Yang IV, Barthel L, Henson PM, Janssen WJ, Schwartz DA, Boucher RC, Dickey BF, Evans CM (2014) Muc5b is required for airway defence. Nature 505(7483):412–416. https://doi.org/10.1038/nature12807 CrossRefPubMed Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, Tuvim MJ, Adachi R, Romo I, Bordt AS, Bowden MG, Sisson JH, Woodruff PG, Thornton DJ, Rousseau K, De la Garza MM, Moghaddam SJ, Karmouty-Quintana H, Blackburn MR, Drouin SM, Davis CW, Terrell KA, Grubb BR, O’Neal WK, Flores SC, Cota-Gomez A, Lozupone CA, Donnelly JM, Watson AM, Hennessy CE, Keith RC, Yang IV, Barthel L, Henson PM, Janssen WJ, Schwartz DA, Boucher RC, Dickey BF, Evans CM (2014) Muc5b is required for airway defence. Nature 505(7483):412–416. https://​doi.​org/​10.​1038/​nature12807 CrossRefPubMed
39.
Zurück zum Zitat Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118(9):1264–1268CrossRefPubMed Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118(9):1264–1268CrossRefPubMed
40.
Zurück zum Zitat Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren’s syndrome. Invest Ophthalmol Vis Sci 39(1):151–156PubMed Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren’s syndrome. Invest Ophthalmol Vis Sci 39(1):151–156PubMed
Metadaten
Titel
Unexplained cough: it is time to rule out Sjogren’s syndrome
verfasst von
Matthew Koslow
Shaye Kivity
Vicktoria Vishnevskia-Dai
Issahar Ben-Dov
Publikationsdatum
31.01.2018
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 5/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-3987-4

Weitere Artikel der Ausgabe 5/2018

Clinical Rheumatology 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.